Adaptimmune Therapeutics logo

ADAP - Adaptimmune Therapeutics News Story

$4.78 -0.1  -2.4%

Last Trade - 07/05/21

Sector
Healthcare
Size
Mid Cap
Market Cap £530.7m
Enterprise Value £267.2m
Revenue £2.83m
Position in Universe 3165th / 6858

BRIEF-Adaptimmune Reports Fourth Quarter Full Year 2020 Results, Business Update

Thu 25th February, 2021 12:51pm
Feb 25 (Reuters) - Adaptimmune Therapeutics PLC  ADAP.O :
    * ADAPTIMMUNE REPORTS FOURTH QUARTER / FULL YEAR 2020
FINANCIAL
RESULTS AND BUSINESS UPDATE
    * ADAPTIMMUNE THERAPEUTICS PLC - FINANCIAL GUIDANCE
CONFIRMED:
FUNDED INTO EARLY 2023
    * ADAPTIMMUNE THERAPEUTICS PLC - REVENUE FOR Q4 WAS $1.5
MILLION
    * ADAPTIMMUNE THERAPEUTICS PLC - QTRLY LOSS PER SHARE $0.15
    * ADAPTIMMUNE THERAPEUTICS - BELIEVES ITS EXISTING CASH,
CASH
EQUIVALENTS AND MARKETABLE SECURITIES WILL FUND CURRENT
OPERATIONS INTO EARLY 2023

Source text for Eikon:  ID:nGNX9pwVnl 
Further company coverage:  ADAP.O 

 ((Reuters.Briefs@thomsonreuters.com;))
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.